Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 26.01.2026 FEX.LN IE00B8X9NW27 1,007,271.00 USD 103,062,660.16 102.319  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 26.01.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,110,518.85 27.515  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 26.01.2026 SDVY.LN IE0001R850E1 10,929,007.00 USD 264,041,187.77 24.160  ...

ORLANDO, Fla.--(BUSINESS WIRE)--Kore.ai, a global leader in enterprise AI and agentic solutions, today announced a strategic growth investment led by AllianceBernstein Private Credit Investors, with continued participation from existing investors Vistara Growth, Beedie Capital and Sweetwater Private Equity. The investment builds on Kore.ai’s strong momentum and long-term investor relationships, and will support the company’s next phase of growth by scaling go-to-market initiatives, deepening gl...

TOKYO & TUALATIN, Ore.--(BUSINESS WIRE)--iGrafx and NTT DATA Intra-mart announced a strategic collaboration to advance Autonomous Operations with process intelligence and execution....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 26.01.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 572,141.32 22.884  ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference at the Cliff Lodge in Snowbird, Utah. About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT Delcath Systems, Inc. is an interventional oncology company focused on the treatmen...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), strengthening its balance sheet and liquidity. Under the terms of the amended loan agreement, up to an additional $75 million will become available upon FDA’s approval of MOLBREEVI, the Company’s investigational therapy in autoimmune pul...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 26.01.2026 GFEB.LN IE000X8M8M80 650,002.00 USD 24,280,256.90 37.354  ...

LONDON--(BUSINESS WIRE)--Adaptive, the leader in custom trading technology solutions, today announced it is developing Aeron Sequencer, a software infrastructure platform designed to tackle the most persistent challenges in modern trading system development: consistency, scalability, performance, and availability. Delivering on these requirements demands niche expertise, large-scale investment, and extended delivery timelines. When done poorly, the consequences can be severe—from regulatory com...